Beth joined Kleiner Perkins Caufield & Byers in May 2005 to work in the life sciences area.For
the past 20 years, she has focused her career on introducing new
innovative treatments for AIDS, arthritis, asthma, cancer, psoriasis,
cardiovascular, metabolic, neurological and renal disorders. She
introduced 10 innovative products to market and achieved over 40
regulatory approvals (including new indications and formulations) on a
worldwide ba...
more
Beth joined Kleiner Perkins Caufield & Byers in May 2005 to work in the life sciences area.
For
the past 20 years, she has focused her career on introducing new
innovative treatments for AIDS, arthritis, asthma, cancer, psoriasis,
cardiovascular, metabolic, neurological and renal disorders. She
introduced 10 innovative products to market and achieved over 40
regulatory approvals (including new indications and formulations) on a
worldwide basis. These products have been successfully commercialized
and have provided benefits to millions of patients with grievous
illnesses and have generated several billion dollars of revenue.
Prior
to joining KPCB, Beth was Senior Vice President, Global Development,
and Chief Medical Officer at Amgen, Inc., the world’s largest
biotechnology company. During Beth’s three years there, her
responsibilities included: all stages of clinical research, regulatory
affairs, safety, health economics/reimbursement and medical affairs.
During her tenure, five innovative products were approved for
commercial use. Prior to joining Amgen, Beth was a senior executive in
research and development at Bristol-Myers Squibb Company and Merck
& Co., Inc. She began her career in basic and clinical research at
the National Institutes of Health specializing in immunology and
infectious diseases.
Beth received her BS from Barnard College
magna cum laude, Phi Beta Kappa; and her medical degree from the
University Of Miami School Of Medicine, alpha omega alpha. Her
post-graduate training was completed at Johns Hopkins, George
Washington School of Medicine and the National Institutes of Health.
She is a member of the Johns Hopkins Bloomberg School of Public Health
Advisory Board and Barnard College Science Advisory Board.
less
